VERA Financial Facts

Selling, general and administrative: 1.89M
Cost of revenues: 1.63M
See Full Income Statement

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY: 14.05M
Total Current Liabilities: 8.06M
See Full Balance Sheet

Vera Therapeutics, Inc. (VERA) Earnings

  |   Expand Research on VERA
Next EPS Date 11/11/26 EPS Growth Rate -27.8%
Average EPS % Beat Rate -18.8% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +7.3% Normal Earnings Time N/A
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/11/26 Q326 N/A-$1.61 N/A N/A$4.28M N/A N/A N/A
8/10/26 Q226 -$1.52-$1.65 +$0.13N/AN/A N/A Details
5/7/26 Q126 -$1.69-$1.33 -$0.36N/AN/A N/A Details
3/19/26 Q425 N/A-$1.28 N/A N/AN/A N/A N/A N/A
11/5/25 Q325 -$1.26-$1.15 -$0.11N/AN/A N/A Details
8/5/25 Q225 -$1.20-$0.82 -$0.38N/AN/A N/A Details
5/6/25 Q125 N/A-$0.73 N/A N/AN/A N/A N/A N/A
3/20/25 Q424 N/A-$0.81 N/A N/AN/A N/A N/A N/A